Ascletis Completes Dosing in U.S. Obesity Study of...
Category : Clinical Trial Update 15 July 2025Ascletis Completes Dosing of All Participants in Its U.S. Clinical Study Combining Adipose-Targeted,...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Revalesio to Present RNS60 Stroke Trial Data at SN...
Category : Clinical Trial Update 15 July 2025Revalesio to Present Phase 3 Trial Design and Post Hoc Analysis of Phase 2 RESCUE Trial of RNS60 in...
Osivax publishes phase 2a results of OVX836-004 st...
Category : Clinical Trial Update 14 July 2025Overview Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protec...
Crinetics to Present Long-Term PALSONIFY™ Data at...
Category : Clinical Trial Update 14 July 2025Overview Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced new data from its clinica...
Ultragenyx, Mereo BioPharma announce UX143 phase 3...
Category : Clinical Trial Update 12 July 2025Overview Ultragenyx Pharmaceutical Inc, a biopharma company committed to bringing novel therapies...
Latest Newsletter Post
-
Revalesio to Present RNS60 Stroke T..
15 July 2025
-
Ascletis Completes Dosing in U.S. O..
15 July 2025
-
Crinetics to Present Long-Term PALS..
14 July 2025
-
Osivax publishes phase 2a results o..
14 July 2025
-
Earendil Labs announces initiation..
12 July 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com